| |
| |
|
| Insider
Information: |
Bird Jeffrey W |
| Relationship: |
Director, 10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
8,735,679 |
|
|
Indirect Shares
|
2,993,315 |
|
|
| Direct
Value |
$121,368,899 |
|
|
|
Indirect Value
|
$14,585,748 |
|
|
| Total
Shares |
11,728,994 |
|
|
| Total
Value |
$135,954,647 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 498.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mattersight Corporation |
MATR |
10% Owner |
2003-09-26 |
0 |
2017-06-01 |
1,128,034 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director, 10% Owner |
2012-03-29 |
5,316,967 |
2011-10-21 |
229,567 |
Premium* |
|
|
Dextera Surgical Inc |
DXTR |
Director, 10% Owner |
2013-03-20 |
3,412,793 |
2013-03-20 |
170,977 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
Director |
2017-06-01 |
919 |
2017-06-01 |
377,782 |
Premium* |
|
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
1,114 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2013-12-13 |
5,000 |
2013-12-13 |
178,406 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
|
Yext Inc |
YEXT |
10% Owner |
|
0 |
2017-12-01 |
724,841 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2017-10-16 |
182,594 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2020-07-02 |
4 |
D |
$18.00 |
$9,251,604 |
I/I |
(513,978) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2020-07-02 |
4 |
D |
$18.00 |
$368,550 |
D/D |
(20,475) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,281 |
20,475 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2019-09-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(921,610) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2019-09-03 |
4 |
A |
$0.00 |
$0 |
I/I |
19,523 |
458,569 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,194 |
13,194 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2018-08-23 |
4 |
B |
$26.65 |
$1,341,810 |
I/I |
50,355 |
449,053 |
2.1 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2018-08-22 |
4 |
B |
$26.09 |
$5,273,006 |
I/I |
202,082 |
398,698 |
2.1 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2018-08-21 |
4 |
B |
$25.17 |
$3,462,571 |
I/I |
137,563 |
196,616 |
2.1 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
0 |
- |
|
| YEXT |
Yext Inc |
10% Owner |
• • • |
2017-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
401,189 |
323,049 |
0 |
- |
|
| YEXT |
Yext Inc |
10% Owner |
• • • |
2017-12-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,614,633) |
0 |
0 |
- |
|
| VERO |
Venus Concept Inc |
Director |
• • • |
2017-10-16 |
4 |
A |
$0.00 |
$828,135 |
I/I |
2,334,913 |
182,594 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2017-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2017-06-01 |
4 |
B |
$31.85 |
$3,804,025 |
I/I |
119,442 |
921,610 |
2.1 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
• • – |
2017-06-01 |
4 |
B |
$0.57 |
$289,773 |
I/I |
510,703 |
377,782 |
2.1 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2017-06-01 |
4 |
B |
$3.65 |
$801,868 |
I/I |
219,732 |
1,056,194 |
1.5 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(147,523) |
810,968 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
• • – |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(630,770) |
3,467,496 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(271,391) |
852,651 |
0 |
- |
|
| YEXT |
Yext Inc |
10% Owner |
• • • |
2017-04-19 |
4 |
A |
$0.00 |
$0 |
I/I |
10,560,198 |
311,959 |
0 |
- |
|
| YEXT |
Yext Inc |
10% Owner |
– – • |
2017-04-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
346,360 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2016-10-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
36,602 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
• • – |
2016-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
96,010 |
340,156 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
